Hydrix Limited delivers product innovation, engineering, and regulatory advisory services across Australia, Singapore, Europe, North America, and other international regions. The company operates through distinct divisions: Hydrix Services, Hydrix Medical, and Hydrix Ventures. Its medical offerings include advanced cardiovascular technologies such as The GUARDIAN, an implantable system designed for monitoring and alerting to cardiac events, which has achieved USA FDA approval; the PHYRARI FFR-Wire, assisting cardiologists in combining diagnostic assessments with therapeutic interventions like stent placement; and LUDO, a flexible platform providing essential tools for the initiation of mechanical circulatory support pump development. Additionally, Hydrix distributes Implicity, a cloud-based, AI-driven platform for remote cardiac patient monitoring and data management. The firm provides a comprehensive range of services, including full product development, critical regulatory and clinical guidance, and technology commercialization strategies. It serves a broad array of sectors including medical, consumer, industrial, utilities, defense, aerospace, and mining. Formerly known as Panorama Synergy Limited, the company adopted the Hydrix Limited name in November 2018. Hydrix Limited was established in 1993 and maintains its headquarters in Mulgrave, Australia.